Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
NovoCure Limited (NVCR) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-06-30, revenue was 699.2m $, net income was -148.6m $.
This summary is compiled automatically from SEC filings and exchange data.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
NovoCure Limited (NVCR) is a company in the Health care sector; its shares trade on Nasdaq.
The price of NovoCure Limited (NVCR) on October 30, 2026 is 13.18 $, +0.50 % on the day. Over 52 weeks the stock traded between 9.82 $ and 21.45 $; the price now sits 29 % of the way up that range. Over the past year the price changed by +5.09 %. Market capitalization is 1.53 billion $, rank 28 among 100 stocks of the same industry with a known capitalization.
NovoCure Limited trades on Nasdaq under the ticker NVCR. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks NVCR has traded between 9.82 $ and 21.45 $. As of 30 October 2026 the price stood 34.56 % of the way from the 52-week low to the high.
Over one year NVCR shares rose 5.09 %; over six months they rose 13.72 %. Volatility over 90 days is 77.65 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.2, below the sector median of 3.6. Price to book is 4.5, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
NovoCure Limited reported revenue of 699M $ and a net loss of 149M $ over the last four quarters. Net margin is −21.25 %. Revenue changed by +10.95 % year over year. Earnings per share are −1.30 $. Market capitalisation is 1.5B $.
NVCR has a return on equity of −43.94 %, below the sector median of −40.58 %. Return on assets is −18.68 %, above the sector median of −30.08 %. Operating margin is −22.08 %, below the sector median of −20.96 %.